Reduced heart rate response to dipyridamole in patients undergoing myocardial perfusion SPECT

Gozde Daglioz Gorur1, Esra Alkan Ciftci, Guliz Kozdag

  • 1Department of Nuclear Medicine, Kocaeli University School of Medicine, Umuttepe, Kocaeli, 41380, Turkey. gozdedaglioz@yahoo.com

Insights

Reduced heart rate (HR) response to dipyridamole is common in myocardial perfusion SPECT imaging. Low high-density lipoprotein (HDL) levels and chronic renal failure predict this reduced HR response, linked to ventricular dysfunction.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Diagnostic Imaging

Background:

  • Dipyridamole is used for myocardial perfusion imaging.
  • A normal hemodynamic response includes increased heart rate (HR).
  • Reduced HR response may indicate underlying pathology.

Purpose of the Study:

  • Investigate HR response to dipyridamole during myocardial perfusion SPECT.
  • Identify predictors of reduced HR response.

Main Methods:

  • 201 patients undergoing dipyridamole stress Tc99m-MIBI or Tl-201 gated myocardial perfusion SPECT were enrolled.
  • Reduced HR response defined as HR ratio (peak HR/rest HR) ≤ 1.20.
  • Logistic regression analysis identified predictors of reduced HR response.

Main Results:

  • 78% of patients exhibited reduced HR response.
  • Predictors included diabetes mellitus, chronic renal failure, and low HDL.
  • Reduced HR response was associated with lower ejection fractions and higher perfusion scores.

Conclusions:

  • Reduced HR response to dipyridamole is linked to ventricular dysfunction and cardiac autonomic neuropathy.
  • Low HDL levels are associated with reduced HR response.
  • Chronic renal failure also predicts reduced HR response.
Abstract

Related Concept Videos